论文信息 - Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study - 字舞流文

Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study

G. Comi | E. Bertini | P. Striano | M. Pane | E. Mercuri | F. Muntoni | L. Santoro | A. D’Amico | C. Angelini | G. Siciliano | C. Bruno | A. Malandrini | F. Santorelli | P. Tonin | M. Grandis | E. Pegoraro | M. Dotti | R. Battini | L. Morandi | A. Pini | R. Guerrini | A. Berardinelli | M. Mora | M. Pinelli | L. Maggi | W. Sanseverino | A. Romano | M. Moggio | L. Politano | R. Massa | C. Rodolico | A. Toscano | C. Battisti | A. Simonati | M. Donati | F. Magri | L. Merlini | C. Fiorillo | A. Rubegni | F. Moro | G. Astrea | R. Trovato | D. Cassandrini | A. Torella | V. Nigro | R. Barresi | E. Picillo | M. Fanin | M. Savarese | E. Pennisi | C. Antozzi | O. Musumeci | L. Peverelli | L. Ruggiero | F. Mari | C. Trevisan | F. Morani | G. Ricci | M. Sacchini | F. Fattori | M. Maioli | I. Pezzini | Irina Zaraieva | Angela Giacomo Maria Alice Maria Teresa Marina Francesca Berardinelli Comi Donati Dotti Grandis Magr | Alessandro Romano

[1] K. Bushby,et al. Mobility shift of beta-dystroglycan as a marker of GMPPB gene-related muscular dystrophy , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[2] K. Bushby,et al. Congenital muscular dystrophies in the UK population: Clinical and molecular spectrum of a large cohort diagnosed over a 12-year period , 2017, Neuromuscular Disorders.

[3] M. Cossée,et al. Muscle involvement in limb-girdle muscular dystrophy with GMPPB deficiency (LGMD2T) , 2016, Neurology: Genetics.

[4] A. D’Amico,et al. TMEM5-associated dystroglycanopathy presenting with CMD and mild limb-girdle muscle involvement , 2016, Neuromuscular Disorders.

[5] D. MacArthur,et al. Diagnosis and etiology of congenital muscular dystrophy: We are halfway there , 2016, Annals of neurology.

[6] Renzhi Cao,et al. 3Drefine: an interactive web server for efficient protein structure refinement , 2016, Nucleic Acids Res..

[7] K. Campbell,et al. GMPPB‐Associated Dystroglycanopathy: Emerging Common Variants with Phenotype Correlation , 2015, Human mutation.

[8] D. MacArthur,et al. Expanding the phenotype of GMPPB mutations. , 2015, Brain : a journal of neurology.

[9] G. Comi,et al. Prevalence of congenital muscular dystrophy in Italy , 2015, Neurology.

[10] A. Gitler,et al. Congenital muscular dystrophy and generalized epilepsy caused by GMPPB mutations , 2014, Brain Research.

[11] R. Vallee,et al. Novel Dynein DYNC1H1 Neck and Motor Domain Mutations Link Distal Spinal Muscular Atrophy and Abnormal Cortical Development , 2014, Human mutation.

[12] Ching H. Wang,et al. Diagnostic approach to the congenital muscular dystrophies , 2014, Neuromuscular Disorders.

[13] Joshua L. Deignan,et al. ACMG clinical laboratory standards for next-generation sequencing , 2013, Genetics in Medicine.

[14] D. MacArthur,et al. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. , 2013, American journal of human genetics.

[15] Eugenio Mercuri,et al. Muscular dystrophies , 2013, The Lancet.

[16] Pascal Benkert,et al. QMEAN server for protein model quality estimation , 2009, Nucleic Acids Res..

[17] Susan C. Brown,et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. , 2007, Brain : a journal of neurology.

[18] Joost Schymkowitz,et al. The stability effects of protein mutations appear to be universally distributed. , 2007, Journal of molecular biology.

[19] E. Mercuri,et al. Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations. , 2006, Archives of neurology.

[20] F. Muntoni,et al. The modulation of skeletal muscle glycosylation as a potential therapeutic intervention in muscular dystrophies. , 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[21] H. Brunner,et al. Glyc‐O‐genetics of Walker–Warburg syndrome , 2004, Clinical genetics.

[22] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[23] Y. Sunada,et al. Fukuyama‐type congenital muscular dystrophy (FCMD) and α‐dystroglycanopathy , 2003 .

[24] Susan C. Brown,et al. Defective glycosylation in muscular dystrophy , 2002, The Lancet.

[25] L. Serrano,et al. Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. , 2002, Journal of molecular biology.

[26] Susan C. Brown,et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. , 2001, Human molecular genetics.

[27] Kevin M Flanigan,et al. The Muscular Dystrophies , 1999, Seminars in Neurology.

[28] P. Lanteri,et al. Mutations in GMPPB Presenting with Pseudometabolic Myopathy. , 2018, JIMD reports.

[29] K. Bushby,et al. This Work Is Licensed under a Creative Commons Attribution 4.0 International License Mutations in Gmppb Cause Congenital Myasthenic Syndrome and Bridge Myasthenic Disorders with Dystroglycanopathies , 2022 .